Clarithromycin for the treatment of pyoderma gangrenosum associated with myelodysplastic syndrome. Korekawa A, Nakajima K, Nakano H, Sawamura D, et al. J Dermatol 2022;49:e131-e132.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Korekawa A, Nakajima K, Nakano H, Sawamura D, et al. Clarithromycin for the treatment of pyoderma gangrenosum associated with myelodysplastic syndrome. J Dermatol 2022;49:e131-e132.
PMID: 34862670